Lenisna 200mg
PDLLA + non-crosslinked HA hybrid biostimulator · 200 mg per vial (PDLLA 170 mg + HA 30 mg) · sold as Lenisna.
Original price was: $199.90.$179.90Current price is: $179.90.
You save
- Lenisna, hailing from Korea, is a skincare formula that merges Hyaluronic Acid and Polylactic Acid (PLA) to catalyze the skin’s own collagen generation. This product triggers the synthesis of collagen, securing sufficient hydration, tightening, and enhancing the skin’s suppleness. Hyaluronic Acid attracts and retains moisture, leading to a noticeably fuller complexion, whereas PLA provides enduring wrinkle reduction by encouraging the skin to produce increased collagen.
Professional use only. This product is intended for administration by licensed healthcare practitioners trained in the relevant anatomy and injection technique. By ordering you confirm you are authorised to purchase and handle products of this class in your jurisdiction. Availability and permitted use vary by country — please verify local regulations before ordering.
Did you like this product? Add to favorites now and follow the product.
(+82) 10 7364 7998 Send a message on WhatsApp.
Lenisna 200mg: a PDLLA + HA hybrid collagen biostimulator
Lenisna 200mg is a hybrid collagen biostimulator from Korea that combines poly-D,L-lactic acid (PDLLA) with non-crosslinked hyaluronic acid (HA) in one vial. Each 200 mg vial contains 170 mg PDLLA, with a particle size of 50 to 60 μm, and 30 mg HA.
Lenisna is the international name for the formulation that VAIM Global markets in Korea as Juvelook Volume, which is also listed separately on our site. The HA component hydrates and gives a fuller look, while the PDLLA component is used to prompt the body’s own collagen, so improvement in firmness builds gradually. It is for use by licensed professionals only.
170 mg PDLLA and 30 mg non-crosslinked HA per vial.
Larger PDLLA particles for deeper structural work.
HA hydrates; PDLLA is used to prompt collagen over time.
Packing unit: 200 mg per vial.
About Lenisna 200mg
Combines a collagen-stimulating polymer with non-crosslinked HA in one product.
170 mg PDLLA per vial, a higher concentration than lower-strength Juvelook products.
Used for firmness, hydration and a fuller look that builds over time.
Listed for deep facial creases, slender faces, facial contours and, on our previous page, the buttocks.
Treatment areas and indications
Areas and concerns where PDLLA + HA hybrids of this strength are used, as listed on our previous page. Approved indications differ by market.
Accentuated lines of the face.
Adding volume to areas that look hollow.
Elevating and defining facial contours.
Skin that looks dull, with early signs of ageing and reduced firmness.
Approvals for body use differ by country.
Lenisna is an injectable medical product. Which indications are permitted and what training is required are set by the regulatory framework where you practise. Korea Filler Experts supplies the product. Nothing here is a recommendation to treat any medical condition, and nothing here replaces manufacturer training.
Lenisna 200mg specification
| Product type | PDLLA + HA hybrid collagen biostimulator |
| PDLLA (poly-D,L-lactic acid) | 170 mg per vial |
| Particle size | 50 to 60 μm |
| Hyaluronic acid | 30 mg per vial, non-crosslinked |
| Packing unit | 200 mg per vial |
| Also sold as | Juvelook Volume (VAIM Global, South Korea) |
| Regulatory status | MFDS-approved (Korea), CE-certified (Europe); not FDA-approved |
| SKU | 06007 |
Before you order
- Regulatory status. This formulation is MFDS-approved and CE-certified. It is not FDA-approved for the US market. Confirm the status in the country where you practise.
- Every vial ships in its original packaging with the lot number and expiry date.
- We do not dispatch stock with under 6 months of shelf life remaining unless agreed in advance.
Priced per vial, with quantity discounts at five, ten and twenty vials.
What each component does
PDLLA, 170 mg
Poly-D,L-lactic acid is a biodegradable polymer used in collagen biostimulators. The particle size in this product is 50 to 60 μm.
Non-crosslinked hyaluronic acid, 30 mg
The HA component attracts and retains water and gives an immediate hydrating effect. It is absorbed over time, so it is not the long-term mechanism of the product.
Lenisna and Juvelook Volume
VAIM Global markets this formulation as Juvelook Volume in Korea and as Lenisna internationally.
Approved indications differ by country. Read the manufacturer’s instructions for use.
How Lenisna is used
Reference information for trained practitioners. The manufacturer’s instructions for use and training take precedence over this page, including reconstitution, needle or cannula, plane and volume per area.
Step by step
-
Assess and consent
Review medical history, allergies, autoimmune disease, scarring tendency, medication and previous fillers. Explain that PDLLA works gradually and that results develop over time.
-
Prepare the skin
Remove make-up and cleanse thoroughly. Apply topical anaesthetic if required.
-
Reconstitute
Reconstitute the powder as stated in the instructions for use, using aseptic technique, immediately before use.
-
Inject as taught
Use the needle or cannula, plane and technique stated in the instructions for use and your training. Inject slowly with low pressure and do not over-correct.
-
Review
Assess the response and decide on any follow-up treatment as a clinical decision.
Administration notes
Do not over-correct. A biostimulator builds its effect gradually, so adding extra product to force an immediate change can lead to lumps or an over-corrected result.
- Single use. One vial, one patient. Discard any remainder.
- Do not inject into infected, inflamed or broken skin.
- Know how to recognise and manage nodules and vascular events.
- Dispose of needles into a sharps container in line with local clinical waste rules.
After treatment
- Redness, swelling, tenderness and bruising are common and settle within days
- Follow the post-treatment advice in the instructions for use and your clinic’s protocol
- Seek urgent review for severe pain, blanching, skin colour change or a lump that grows or becomes tender
Storing and handling Lenisna 200mg
Store as stated in the instructions for use, protected from direct sunlight. Do not freeze.
Use before the expiry date, and only if the packaging and vial are intact.
Use immediately. Single patient, single session. Do not retain or reuse any remainder.
Do not use if the packaging is damaged or the expiry date has passed. Dispose of used vials, syringes and needles as clinical waste in line with local requirements.
What's included with Lenisna 200mg
Reconstitution fluids, syringes, needles, cannulas and anaesthetic are not supplied unless stated in the manufacturer’s pack.
Lenisna 200mg — frequently asked questions
What is Lenisna 200mg?
A hybrid collagen biostimulator from Korea with 170 mg PDLLA and 30 mg non-crosslinked HA per 200 mg vial.
Is Lenisna the same as Juvelook Volume?
Yes. VAIM Global markets this formulation as Juvelook Volume in Korea and as Lenisna internationally. Juvelook Volume is listed separately on our site.
What does each component do?
The HA hydrates and gives a fuller look. The PDLLA is used to prompt the body’s own collagen, so improvement in firmness builds gradually.
Is it FDA-approved?
No. It is MFDS-approved in Korea and CE-certified in Europe. It is not FDA-approved for the US market.
Which areas is it used on?
Our listing names deep facial creases and lines, slender faces, facial contours and, on our previous page, the buttocks. Approvals for body use differ by country.
Who can buy and use this product?
Injectable products are for administration by licensed healthcare practitioners trained in injection technique. We supply qualified professionals and do not sell to consumers.
Copyright 2026 © Korea Filler Experts. All right reserved.
